Inventor · disambiguated record
Andras Gruber
Also filed as: GRUBER ANDRAS
18 granted patents·9 pending applications·238 citations·filing 1987–2023
95Inventor score
Top patents by PatentIndex Score
27 records- 0195US9636399B2Anti-factor XI monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted May 2, 2017·15 cites·22 claims
- 0295US8236316B2Anti-factor XI monoclonal antibodies and methods of use thereofGRUBER ANDRAS·Filed 2008·Granted Aug 7, 2012·33 cites·24 claims
- 0394US9125895B2Anti-factor XI monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Sep 8, 2015·19 cites·15 claims
- 0493US8388959B2Anti-fXI antibodies and methods of useGRUBER ANDRAS·Filed 2009·Granted Mar 5, 2013·29 cites·22 claims
- 0591US9637550B2Anti-fXI antibodies and methods of useUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted May 2, 2017·14 cites·21 claims
- 0691US8940883B2Anti-fXI antibodies and methods of useUNIV OREGON HEALTH & SCIENCE·Filed 2013·Granted Jan 27, 2015·15 cites·12 claims
- 0791US8399648B2Polynucleotides encoding anti-factor XI monoclonal antibodies and methods of use thereofGRUBER ANDRAS·Filed 2012·Granted Mar 19, 2013·14 cites·14 claims
- 0886US5084274AInhibition of arterial thrombotic occlusion or thromboembolismSCRIPPS CLINIC RES·Filed 1987·Granted Jan 28, 1992·39 cites·36 claims
- 0983US9574013B2Antibodies against factor XII and uses thereofUNIV VANDERBILT·Filed 2013·Granted Feb 21, 2017·7 cites·20 claims
- 1083US2023340501A1Coordinated coexpression of thrombinABSCI CORP·Filed 2023·Application pending·0 cites
- 1175US7223583B2Antithrombotic thrombin variantsUNIV EMORY·Filed 2003·Granted May 29, 2007·5 cites·9 claims
- 1270US5288612AAssay methods for detecting serum proteases, particularly activated protein CSCRIPPS RESEARCH INST·Filed 1991·Granted Feb 22, 1994·30 cites·9 claims
- 1369US10577428B2Anti-factor XI monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2018·Granted Mar 3, 2020·0 cites·19 claims
- 1467US6706512B2Antithrombotic thrombin variantsUNIV EMORY·Filed 2002·Granted Mar 16, 2004·7 cites·14 claims
- 1567US2020063116A1Coordinated coexpression of thrombinARONORA INC·Filed 2019·Application pending·0 cites
- 1662US2017204195A1Anti-factor xi monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2017·Application pending·0 cites
- 1762US2013171144A1Anti-factor xi monoclonal antibodies and methods of use thereofUNIV OREGON HEALTH & SCIENCE·Filed 2013·Application pending·0 cites
- 1855US5350578AInhibition of arterial thrombotic occlusion or thromboembolismSCRIPPS CLINIC RES·Filed 1991·Granted Sep 27, 1994·10 cites·14 claims
- 1954US12134657B2Therapeutic factor XII antibodyUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Nov 5, 2024·0 cites·21 claims
- 2053US8940297B2Expression of thrombin variantsDI CERA ENRICO·Filed 2011·Granted Jan 27, 2015·1 cites·9 claims
- 2152US12496311B2Methods for safely reducing thrombopoietinARONORA INC·Filed 2019·Granted Dec 16, 2025·0 cites·16 claims
- 2251US2010158890A1Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitorsTANAKA KENICHI·Filed 2007·Application pending·0 cites
- 2347US2013064807A1Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitorsUNIV OREGON HEALTH & SCIENCE·Filed 2012·Application pending·0 cites
- 2442US2010184672A1Protein c for use in maintaining hemostasisMCCARTY OWEN J T·Filed 2008·Application pending·0 cites
- 2540US2008219998A1Anti-Thrombotic AgentsGRUBER ANDRAS·Filed 2002·Application pending·0 cites
- 2639US2022089777A1Novel humanized antibodies against factor xi having anti-thrombotic and anti-inflammatory effect and uses thereofARONORA INC·Filed 2020·Application pending·0 cites
- 2737US10508270B2Coordinated coexpression of thrombinARONORA INC·Filed 2014·Granted Dec 17, 2019·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Andras Gruber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →